The Defense Logistics Agency Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to Access Bio, Inc., a minority-owned, for-profit, Asian-Pacific American manufacturer of goods. The IDC has a potential value of $410.4 million and runs through November 2023, with the purpose of procuring COVID-19 related products and services.
Under this IDC, the Defense Logistics Agency Troop Support Medical issued a $205.2 million firm fixed-price delivery order to Access Bio, Inc. to provide CareStart COVID-19 antigen tests. This delivery order will be performed in Somerset, Franklin Township, New Jersey from December 22, 2022 through May 11, 2023, with Access Bio, Inc. serving as the prime contractor. The contracted COVID-19 tests and related products and services aim to support the agency's COVID-19 testing requirements.
Generated 3/30/24, 9:24 AM